NCT02998216

Brief Summary

This study aims to the assessment of pelvic floor symptoms and patients´ satisfaction after bilateral sacrospinous fixation for the primary treatment of pelvic organ prolapse stage IV.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 20, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

December 20, 2016

Status Verified

November 1, 2016

Enrollment Period

1 year

First QC Date

November 11, 2016

Last Update Submit

December 15, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of pelvic floor symptoms

    Using the validated Germen Pelvic Floor Questionnaire (Baessler et al, Neurourol Urodynam 2004)

    Twelve months

Secondary Outcomes (3)

  • Anatomical outcome / Prolapse stage after surgery

    Twelve months

  • Changes in quality of life

    Twelve months

  • Changes in sexual activity

    Twelve months

Interventions

Bilateral sacrospinous vaginal suspension

Also known as: Bilateral sacrospinous vaginal suspension

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All female patients who are planned to receive a bilateral sacrospinous fixation as a treatment for pelvic organ prolapse Stage IV will be eligible for inclusion in the study.

You may qualify if:

  • age 18 and above
  • pelvic organ prolapse ICS-POPQ Stage IV, with or without uterus
  • signed informed consent

You may not qualify if:

  • gynecologic surgery in the three past months before planned surgery
  • history of prolapse surgery
  • participation in another study
  • need to simultaneously perform other surgical procedures (i.e. rectopexy)
  • ongoing chemotherapy of treatment with immunosuppressant drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Tuebingen

Tübingen, Baden-Wurttemberg, 72072, Germany

RECRUITING

Related Publications (1)

  • Kavvadias T, Schoenfisch B, Brucker SY, Reisenauer C. Anatomical and functional outcomes after hysterectomy and bilateral sacrospinous ligament fixation for stage IV uterovaginal prolapse: a prospective case series. BMC Urol. 2020 Aug 19;20(1):126. doi: 10.1186/s12894-020-00694-3.

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Christl Reisenauer, Professor

    Universitys Hospital Tuebingen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2016

First Posted

December 20, 2016

Study Start

May 1, 2016

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

December 20, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations